Europe Nerve Repair And Regeneration Market Size & Outlook
The nerve repair and regeneration market in Europe is expected to reach a projected revenue of US$ 6,082.7 million by 2030. A compound annual growth rate of 12.7% is expected of Europe nerve repair and regeneration market from 2024 to 2030.
Europe nerve repair and regeneration market highlights
The Europe nerve repair and regeneration market generated a revenue of USD 2,635.0 million in 2023.
The market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
In terms of segment, neurostimulation and neuromodulation devices was the largest revenue generating product in 2023.
Biomaterials is the most lucrative product segment registering the fastest growth during the forecast period.
Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
Market revenue in 2023
USD 2,635.0 million
Market revenue in 2030
USD 6,082.7 million
Growth rate
12.7% (CAGR from 2023 to 2030)
Largest segment
Neurostimulation and neuromodulation devices
Fastest growing segment
Biomaterials
Historical data covered
2018 - 2022
Base year for estimation
2023
Forecast period covered
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Biomaterials, Neurostimulation and Neuromodulation Devices
Key market players worldwide
Axogen Inc, Stryker Corp, St. Jude Medical, Baxter International Inc, Boston Scientific Corp, Integra Lifesciences Holdings Corp, Medtronic PLC, Polyganics, LivaNova PLC
Other key industry trends
In terms of revenue, Europe region accounted for 28.8% of the global nerve repair and regeneration market in 2023.
Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 5,642.7 million by 2030.
Europe follows North America in terms of share of nerve repair and regeneration market. Presence of well-established medical centers providing stimulation therapy is a high-impact rendering driver for growth in this region. On an average, almost 0.3 million people suffer from peripheral nerve injuries every year causing morbidity and disability.
In addition, increase in the number of government-funded research projects, such as IMPACT, to promote awareness and improve quality of patients’ lives is anticipated to fuel the growth of nerve repair and regeneration market. Industry players are also striving to capitalize opportunities in this region.
In April 2021, Polyganics, a medical device firm that develops, manufactures, and sells bioresorbable medical devices, announced its relocation to a state-of-the-art, purpose-built facility on Groningen's Zernike Campus. Polyganics' research laboratories, manufacturing and packaging facilities, and offices will all be housed in the new structure.
Europe Nerve Repair And Regeneration Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nerve Repair And Regeneration Market Outlook will help companies and investors design strategic landscapes.
Neurostimulation And Neuromodulation Devices was the largest segment with a revenue share of 66.67% in 2023.
Horizon Databook has segmented the Europe nerve repair and regeneration market based on biomaterials, neurostimulation and neuromodulation devices covering the revenue growth of each sub-segment from 2018 to 2030.
Europe follows North America in terms of share of nerve repair and regeneration market. Presence of well-established medical centers providing stimulation therapy is a high-impact rendering driver for growth in this region. On an average, almost 0.3 million people suffer from peripheral nerve injuries every year causing morbidity and disability.
In addition, increase in the number of government-funded research projects, such as IMPACT, to promote awareness and improve quality of patients’ lives is anticipated to fuel the growth of nerve repair and regeneration market. Industry players are also striving to capitalize opportunities in this region.
In April 2021, Polyganics, a medical device firm that develops, manufactures, and sells bioresorbable medical devices, announced its relocation to a state-of-the-art, purpose-built facility on Groningen's Zernike Campus. Polyganics' research laboratories, manufacturing and packaging facilities, and offices will all be housed in the new structure.
Europe Nerve Repair And Regeneration Market Product Outlook (Revenue, USD Million , 2018-2030)
Biomaterials
Neurostimulation and Neuromodulation Devices
Europe Nerve Repair And Regeneration Market Surgery Outlook (Revenue, USD Million , 2018-2030)
Direct Nerve Repair/Neurorrhaphy
Nerve Grafting
Stem Cell Therapy
Neurostimulation and Neuromodulation Surgeries
Reasons to subscribe to Nerve Repair And Regeneration Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nerve Repair And Regeneration Market Outlook databook
Our clientele includes a mix of Nerve Repair And Regeneration Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Nerve Repair And Regeneration Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Nerve Repair And Regeneration Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Europe Nerve Repair And Regeneration Market, 2018-2030 (US$M)